Fed. Circ. Revives Jury Ax Of Biogen MS Drug Patent
A New Jersey federal judge shouldn't have overridden a jury verdict invalidating claims of a Biogen patent covering the blockbuster multiple sclerosis treatment Avonex, the Federal Circuit said Monday....To view the full article, register now.
Already a subscriber? Click here to view full article